About Carol

Carol focuses her practice on formulating and executing patent and market exclusivity strategies consistent with biotechnology and pharmaceutical companies' business goals. She has extensive experience in strategic patent counseling and patent portfolio management, preparation and worldwide prosecution of patent applications, intellectual property due diligence, freedom to operate analyses and legal opinions. In addition, Carol counsels investors and companies with respect to intellectual property issues related to potential investments, acquisitions and licensing and partnering opportunities.

View full bio

Experience

  • Archon Biosciences Announces $20 Million Seed Financing

    • Archon Biosciences Announces $20 Million Seed Financing

    October 30, 2024

    Cooley advised Archon Biosciences, a biotechnology company pioneering computationally designed antibody cages (AbCs) to unlock powerful therapeutic targets beyond the reach of existing modalities, on its $20 million seed financing led by Madrona Ventures.

    Read more

    Related contacts

    Colleen Badgley
    Partner, Seattle
    Alan W. Tamarelli
    Partner, New York
    Willy Cowles
    Associate, Seattle
    Lucy Bauer
    Associate, Seattle
    Brian Woodard
    Paralegal Specialist, Seattle
    John Sellers
    Senior Counsel, Palo Alto
    Timothy Shapiro
    Partner, Palo Alto
    Dr. Carol Laherty
    Partner, Seattle
    Millie Heuer
    Associate, Seattle

    Related Practices & Industries

    Emerging Companies
    Life Sciences and Healthcare
    Biotechnology
    Patent Counseling and Prosecution
    Tax
    Artificial Intelligence

  • Egalet Corporation IPO

    • Egalet Corporation IPO

    February 21, 2014

    New York – Cooley advised the underwriters on Egalet's initial public offering. Egalet is a specialty pharmaceutical company that develops and plans to commercialize abuse-deterrent oral products. Egalet now trades on the Nasdaq Global Market under the symbol "EGLT."

    Stifel Nicolaus and JMP Securities acted as joint book-running managers for the offering. Canaccord Genuity and Janney Montgomery Scott acted as co-managers.

    This offering follows Cooley's record year in 2013 for capital markets in which the firm advised on 60 public offerings, including 23 IPOs, raising more than $8.4 billion. Year-to-date in 2014, Cooley has advised on 22 completed public offerings, including 12 completed IPOs.

    Related contacts

    Babak (Bo) Yaghmaie
    Partner, New York
    Natasha Leskovsek
    Of Counsel, Washington, DC
    Dr. Carol Laherty
    Partner, Seattle
    Kenneth Krisko
    Partner, Reston

  • Epizyme, Inc. Initial Public Offering

    • Epizyme, Inc. Initial Public Offering

    June 14, 2013

    San Francisco – Cooley advised the underwriters on Epizyme's recent IPO. Epizyme, now trading on the Nasdaq Global Stock Market under the symbol "EPZM," is a Massachusetts based biopharmaceutical company that discovers, develops and plans to commercialize innovative personalized therapeutics for patients with genetically defined cancers.

    Citigroup Global Markets, Cowen and Co. and Leerink Swann acted as lead joint book-running managers for the offering. JMP Securities and Wedbush Securities acted as co-managers.

    Based on the American Lawyer's 2012 Corporate Scorecard, Cooley served as issuer counsel on 40 total US equity offerings, ranking as the most active law firm advising issuers in the country. Cooley was also the third most active law firm advising underwriters on US IPOs.

    Related contacts

    Drew Williamson
    Partner, San Francisco
    Kenneth Krisko
    Partner, Reston
    Jennifer Raab
    Partner, Palo Alto
    Dr. Carol Laherty
    Partner, Seattle
    Natasha Leskovsek
    Of Counsel, Washington, DC

Admissions and credentials

  • Registered to practice before the United States Patent and Trademark Office (USPTO)
  • Washington

Rankings and accolades

Chambers USA: Intellectual Property – Washington (2022 – 2025)

Chambers: Leading Patent Lawyer

Best Lawyers: Leading Patent Lawyer

IAM Patent 1000: Top Patent Lawyer

Memberships and affiliations

  • Washington State Patent Law Association

Cooley Protect

Empowering entrepreneurs and growth companies

Learn more

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.